Logo-bi
Original Research

1. Non-invasive serum fibrosis markers: A study in chronic hepatitis
Mohammadreza Abdollahi, Aliasghar Pouri*, Morteza Ghojazadeh, Rasoul Estakhri, Mohammadhossein Somi
Bioimpacts. 2015;5(1): 17-23. doi: 10.15171/bi.2015.05
PMCID: PMC4401163     PMID: 25901293     Scopus ID: 84924853426    
Article
PDF
XML
Cited By:
33
11
30
Perspective

2. SARS-CoV-2 and probable lung cancer risk
Sajad Khiali ORCID, Afra Rezagholizadeh ORCID, Taher Entezari-Maleki* ORCID
BioImpacts. 2022;12(3): 291-292. doi: 10.34172/bi.2022.23266
PMCID: PMC9124879     PMID: 35677665     Scopus ID: 85132071249    
Article
PDF
Full Text
XML
Cited By:
8
0
5
In the present perspective piece, three possible mechanisms of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an oncogenic virus in the lung have been discussed.
Original Article

3. Autophagy-induced mesenchymal stem cell-derived extracellular vesicles ameliorated renal fibrosis in an in vitro model
Behnaz Ahrabi ORCID, Hojjat Allah Abbaszadeh* ORCID, Abbas Piryaei, Faezeh Shekari, Navid Ahmady Roozbahany, Mahya Rouhollahi, Forough Azam Sayahpour, Mahnaz Ahrabi, Hadi Azimi, Reza Moghadasali* ORCID
Bioimpacts. 2023;13(5): 359-372. doi: 10.34172/bi.2022.24256
PMCID: PMC10509741     PMID: 37736337     Scopus ID: 85170678712    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Original Article

4. Comparison the therapeutic effects of bone marrow CD144+ endothelial cells and CD146+ mesenchymal stem cells in POF rats

Nahideh Nazdikbin Yamchi ORCID, Farhad Amjadi, Rahim Beheshti, Mehdi Hassanpour, Reza Shirazi, Amin Tamadon ORCID, Reza Rahbarghazi ORCID, Mahdi Mahdipour* ORCID
Bioimpacts. 2023;13(6): 495-504. doi: 10.34172/bi.2023.27781
PMCID: PMC10676523     PMID: 38022384     Scopus ID: 85172811127    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Systematic Review

5. The effectiveness of antioxidant agents in delaying progression of diabetic nephropathy: A systematic review of randomized controlled trials
Ika Rahayu ORCID, Nur Arfian* ORCID, Christina Yeni Kustanti ORCID, Mae Sri Hartati Wahyuningsih ORCID
Bioimpacts. 2025;15: 30129 | Published on: 2024 Jun 19. doi: 10.34172/bi.30129
PMCID: PMC11830129     PMID: 39963561    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
0
0
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons